Shaanxi Meibang Pharmaceutical Group Co., Ltd.
605033.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.67B
Close$
$4.63
76% downside
Current Fair Value
76% downsideOvervalued by 76% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.67 Billion |
|---|---|
| Enterprise Value | $2.62 Billion |
| Dividend Yield | $0.15 (0.76%) |
| Earnings per Share | $0.36 |
| Beta | 0.42 |
| Outstanding Shares | 131,775,504 |
Return
| Return on Equity | 5.34% |
|---|---|
| Return on Assets | 3.43% |
| Return on Invested Capital | 5.54% |
Valuation & Multiples
| P/E Ratio | 41.79 |
|---|---|
| PEG | 27.91 |
| Price to Sales | 2.75 |
| Price to Book Ratio | 2.14 |
| Enterprise Value to Revenue | 2.66 |
| Enterprise Value to EBIT | 31.24 |
| Enterprise Value to Net Income | 41 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shaanxi Meibang Pharmaceutical Group Co., Ltd.
1,117 employees
CEO: Tong Zhang Established in Weinan, China, in 1998, Shaanxi Meibang Pharmaceutical Group Co., Ltd. operates within the agricultural chemicals sector. The company is dedicated to the research, development, manufacturing, and commercialization of pesti...